Open Access Journal of Biomedical Science | Biomedscis

Atypical Melanoma Misdiagnosed as Viral Meningoencephalitis: A Case Report by Lirong Wu* in Open Access Journal of Biomedical Science (OAJBS) As a rare disease with diverse clinical symptoms, primary intracranial malignant melanoma is usually misdiagnosed. We describe a patient who presented intracranial hypertension with abnormal signals in the left temporal lobe. The result of cerebrospinal fluid (CSF) analysis was consistent with the signs of viral meningoencephalitis, so antiviral and nutritional support was given, his headache relieved with normal intracranial pressure. The symptoms of the patients were repeated, and the left temporal lobe lesion was unknown. Surgical biopsy confirmed it was malignant melanoma lastly. This case highlights the brain biopsy in facilitating a highly accurate diagnosis rate. https://biomedscis.com/fulltext/atypical-melanoma-misdiagnosed-as-viral-meningoencephalitis-a-case-report.ID.000258.php To Know More About Open Access Journal of Biomedical Sc

Brain Stimulation Therapy in Patients with Parkinson’s Disease by Bykov YN* in Open Access Journal of Biomedical Science (OAJBS) Parkinson’s disease (PD) is wide-spread nosology around the globe. Clinical features of PD consist of motor and non-motor disorders. Motor disorders include such symptoms as tremor, hypokinesia, rigidity, postural instability. Non-motor disorders include cognitive and emotional impairments, sleep disorders and vegetative disturbance. There are medication and non-medicated methods of treatment in Parkinson’s disease. Brain stimulations may be perspective methods in complex therapy of PD patients. https://biomedscis.com/fulltext/brain-stimulation-therapy-in-patients-with-parkinsons-disease.ID.000257.php To Know More About Open Access Journal of Biomedical Science Please Visit: Biomedscis Are Click on:   https://Biomedscis.Com/  

  MicroRNA as a New Blood-Borne Novel Biomarker for the Earlier Diagnosis of Lung Cancer by Muhammad Siraj* in Open Access Journal of Biomedical Science (OAJBS) Throughout the world, lung cancer is the first leading cause of cancer-related death, estimating roundabout 1.6 million cancer deaths occur annually. Lung cancer with its highest incident and deaths/mortality all over the world due to its limited diagnosis and treatment strategies. The earlier diagnosis of lung cancer plays an important in its treatment. There are different techniques used for the diagnosis of lung cancer including sputum cytology, different nanoparticles, and biomarkers such as CYFRA 21-1, NSE, SCC, CEA, ProGRP, Tumor M2-PK, miRNA. The main objective of this study is the role of miRNA as a novel biomarker for the earlier diagnosis of lung cancer. MicroRNAs are a very effective diagnosis marker for the earlier detection of lung cancer with high specificity and sensitivity about 96.6% and 86.2% respectivel